InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-47.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by O'Brien James Michael, 首席财务官. Director active across 1 company, notably Cognition Therapeutics INC. Cumulatively, 1 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €52k. History available since 13 October 2021. The latest transaction was filed on 13 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to O'Brien James Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
5,000 股@ US$12.00100.0% 占其流量Common StockSEC:0001104659-21-126361:0
标准退出：2022年1月11日 (T+90)
1 条申报中的 1 条
About O'Brien James Michael
James Michael O'Brien is the Chief Financial Officer at COGNITION THERAPEUTICS INC. He oversees the financial operations of the company, including risk management and strategic planning. James plays a key role in financial strategy and the company's growth.
